Literature DB >> 18070956

In vitro antimycobacterial activities of capuramycin analogues.

Venkata M Reddy1, Leo Einck, Carol A Nacy.   

Abstract

Translocase I inhibitor compounds derived from capuramycin demonstrated rapid bactericidal activity against several different mycobacterial species. SQ641 was the most active of the compounds, with a MIC of 0.12 to 8 microg/ml, a postantibiotic effect of 55 h, and interesting synergistic effects with other antitubercular drugs.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18070956      PMCID： PMC2224724          DOI： 10.1128/AAC.01469-07

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  11 in total

1.  Susceptibility testing of slowly growing mycobacteria by a microdilution MIC method with 7H9 broth.

Authors:  R J Wallace; D R Nash; L C Steele; V Steingrube
Journal:  J Clin Microbiol       Date:  1986-12       Impact factor: 5.948

2.  Identification of a novel peptidoglycan hydrolase CwlM in Mycobacterium tuberculosis.

Authors:  Lingyi Lynn Deng; Donald E Humphries; Robert D Arbeit; Laura E Carlton; Sandra C Smole; J David Carroll
Journal:  Biochim Biophys Acta       Date:  2004-11-11

Review 3.  Recent advances in antimicrobial nucleoside antibiotics targeting cell wall biosynthesis.

Authors:  Ken-ichi Kimura; Timothy D H Bugg
Journal:  Nat Prod Rep       Date:  2003-04       Impact factor: 13.423

4.  Activity of capuramycin analogues against Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium intracellulare in vitro and in vivo.

Authors:  Tetsufumi Koga; Takashi Fukuoka; Norio Doi; Tamako Harasaki; Harumi Inoue; Hitoshi Hotoda; Masayo Kakuta; Yasunori Muramatsu; Naotoshi Yamamura; Misa Hoshi; Takashi Hirota
Journal:  J Antimicrob Chemother       Date:  2004-09-03       Impact factor: 5.790

5.  Studies on novel bacterial translocase I inhibitors, A-500359s. II. Biological activities of A-500359 A, C, D and G.

Authors:  Yasunori Muramatsu; Michiko Miyazawa Ishii; Masatoshi Inukai
Journal:  J Antibiot (Tokyo)       Date:  2003-03       Impact factor: 2.649

6.  Studies on novel bacterial translocase I inhibitors, A-500359s. I. Taxonomy, fermentation, isolation, physico-chemical properties and structure elucidation of A-500359 A, C, D and G.

Authors:  Yasunori Muramatsu; Akiko Muramatsu; Takashi Ohnuki; Michiko Miyazawa Ishii; Masaaki Kizuka; Ryuzo Enokita; Shinya Tsutsumi; Masatoshi Arai; Yasumasa Ogawa; Toshihiro Suzuki; Toshio Takatsu; Masatoshi Inukai
Journal:  J Antibiot (Tokyo)       Date:  2003-03       Impact factor: 2.649

7.  In vitro activity of the benzoxazinorifamycin KRM-1648 against drug-susceptible and multidrug-resistant tubercle bacilli.

Authors:  J Luna-Herrera; M V Reddy; P R Gangadharam
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

8.  In vitro postantibiotic effects of rifapentine, isoniazid, and moxifloxacin against Mycobacterium tuberculosis.

Authors:  Chiu-Yeung Chan; Carrie Au-Yeang; Wing-Wai Yew; Chi-Chiu Leung; Augustine F B Cheng
Journal:  Antimicrob Agents Chemother       Date:  2004-01       Impact factor: 5.191

9.  Capuramycin, a new nucleoside antibiotic. Taxonomy, fermentation, isolation and characterization.

Authors:  H Yamaguchi; S Sato; S Yoshida; K Takada; M Itoh; H Seto; N Otake
Journal:  J Antibiot (Tokyo)       Date:  1986-08       Impact factor: 2.649

10.  Assessment of immunity to mycobacterial infection with luciferase reporter constructs.

Authors:  V A Snewin; M P Gares; P O Gaora; Z Hasan; I N Brown; D B Young
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441
View more
  29 in total

1.  Chemical modification of capuramycins to enhance antibacterial activity.

Authors:  Elena Bogatcheva; Tia Dubuisson; Marina Protopopova; Leo Einck; Carol A Nacy; Venkata M Reddy
Journal:  J Antimicrob Chemother       Date:  2010-12-23       Impact factor: 5.790

Review 2.  New antituberculous drugs derived from natural products: current perspectives and issues in antituberculous drug development.

Authors:  Masayuki Igarashi; Yoshimasa Ishizaki; Yoshiaki Takahashi
Journal:  J Antibiot (Tokyo)       Date:  2017-11-01       Impact factor: 2.649

3.  Optimization of cell receptor-specific targeting through multivalent surface decoration of polymeric nanocarriers.

Authors:  Suzanne M D'Addio; Steven Baldassano; Lei Shi; Lila Cheung; Douglas H Adamson; Matthew Bruzek; John E Anthony; Debra L Laskin; Patrick J Sinko; Robert K Prud'homme
Journal:  J Control Release       Date:  2013-02-16       Impact factor: 9.776

4.  Improved synthesis of capuramycin and its analogues.

Authors:  Yong Wang; Shajila Siricilla; Bilal A Aleiwi; Michio Kurosu
Journal:  Chemistry       Date:  2013-09-06       Impact factor: 5.236

5.  In vitro interactions between new antitubercular drug candidates SQ109 and TMC207.

Authors:  Venkata M Reddy; Leo Einck; K Andries; Carol A Nacy
Journal:  Antimicrob Agents Chemother       Date:  2010-04-12       Impact factor: 5.191

6.  A biocatalytic approach to capuramycin analogues by exploiting a substrate permissive N-transacylase CapW.

Authors:  Xiaodong Liu; Yuanyuan Jin; Wenlong Cai; Keith D Green; Anwesha Goswami; Sylvie Garneau-Tsodikova; Koichi Nonaka; Satoshi Baba; Masanori Funabashi; Zhaoyong Yang; Steven G Van Lanen
Journal:  Org Biomol Chem       Date:  2016-04-06       Impact factor: 3.876

Review 7.  New agents for the treatment of drug-resistant Mycobacterium tuberculosis.

Authors:  Daniel T Hoagland; Jiuyu Liu; Robin B Lee; Richard E Lee
Journal:  Adv Drug Deliv Rev       Date:  2016-05-02       Impact factor: 15.470

8.  The Biosynthesis of Capuramycin-type Antibiotics: IDENTIFICATION OF THE A-102395 BIOSYNTHETIC GENE CLUSTER, MECHANISM OF SELF-RESISTANCE, AND FORMATION OF URIDINE-5'-CARBOXAMIDE.

Authors:  Wenlong Cai; Anwesha Goswami; Zhaoyong Yang; Xiaodong Liu; Keith D Green; Sandra Barnard-Britson; Satoshi Baba; Masanori Funabashi; Koichi Nonaka; Manjula Sunkara; Andrew J Morris; Anatol P Spork; Christian Ducho; Sylvie Garneau-Tsodikova; Jon S Thorson; Steven G Van Lanen
Journal:  J Biol Chem       Date:  2015-04-08       Impact factor: 5.157

9.  DPAGT1 Inhibitors of Capuramycin Analogues and Their Antimigratory Activities of Solid Tumors.

Authors:  Katsuhiko Mitachi; Rita G Kansal; Kirk E Hevener; Cody D Gillman; Syed M Hussain; Hyun Gi Yun; Gustavo A Miranda-Carboni; Evan S Glazer; William M Clemons; Michio Kurosu
Journal:  J Med Chem       Date:  2020-09-18       Impact factor: 7.446

10.  Biosynthesis of a water-soluble lipid I analogue and a convenient assay for translocase I.

Authors:  Shajila Siricilla; Katsuhiko Mitachi; Karolina Skorupinska-Tudek; Ewa Swiezewska; Michio Kurosu
Journal:  Anal Biochem       Date:  2014-06-02       Impact factor: 3.365
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.